CCPortal
DOI10.1126/science.aay5051
De novo protein design enables the precise induction of RSV-neutralizing antibodies
Sesterhenn F.; Yang C.; Bonet J.; Cramer J.T.; Wen X.; Wang Y.; Chiang C.-I.; Abriata L.A.; Kucharska I.; Castoro G.; Vollers S.S.; Galloux M.; Dheilly E.; Rosset S.; Corthésy P.; Georgeon S.; Villard M.; Richard C.-A.; Descamps D.; Delgado T.; Oricchio E.; Rameix-Welti M.-A.; Más V.; Ervin S.; Eléouët J.-F.; Riffault S.; Bates J.T.; Julien J.-P.; Li Y.; Jardetzky T.; Krey T.; Correia B.E.
发表日期2020
ISSN0036-8075
卷号368期号:6492
英文摘要De novo protein design has been successful in expanding the natural protein repertoire. However, most de novo proteins lack biological function, presenting a major methodological challenge. In vaccinology, the induction of precise antibody responses remains a cornerstone for next-generation vaccines. Here, we present a protein design algorithm called TopoBuilder, with which we engineered epitope-focused immunogens displaying complex structural motifs. In both mice and nonhuman primates, cocktails of three de novo–designed immunogens induced robust neutralizing responses against the respiratory syncytial virus. Furthermore, the immunogens refocused preexisting antibody responses toward defined neutralization epitopes. Overall, our design approach opens the possibility of targeting specific epitopes for the development of vaccines and therapeutic antibodies and, more generally, will be applicable to the design of de novo proteins displaying complex functional motifs. Copyright © 2020 The Authors,
关键词algorithmantibodydesignneutralizationproteinvaccineMusPrimatesRespiratory syncytial virusRice stripe virusepitopefusion proteinnanobodyneutralizing antibodyrespiratory syncytial virus vaccinebiologybiosynthesischemistryhumanHuman respiratory syncytial virusimmunologyproceduresprotein conformationprotein engineeringprotein motifAmino Acid MotifsAntibodies, NeutralizingComputational BiologyHumansImmunodominant EpitopesProtein ConformationProtein EngineeringRecombinant Fusion ProteinsRespiratory Syncytial Virus VaccinesRespiratory Syncytial Virus, HumanSingle-Domain Antibodies
语种英语
来源机构Science
文献类型期刊论文
条目标识符http://gcip.llas.ac.cn/handle/2XKMVOVA/133497
推荐引用方式
GB/T 7714
Sesterhenn F.,Yang C.,Bonet J.,et al. De novo protein design enables the precise induction of RSV-neutralizing antibodies[J]. Science,2020,368(6492).
APA Sesterhenn F..,Yang C..,Bonet J..,Cramer J.T..,Wen X..,...&Correia B.E..(2020).De novo protein design enables the precise induction of RSV-neutralizing antibodies.,368(6492).
MLA Sesterhenn F.,et al."De novo protein design enables the precise induction of RSV-neutralizing antibodies".368.6492(2020).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Sesterhenn F.]的文章
[Yang C.]的文章
[Bonet J.]的文章
百度学术
百度学术中相似的文章
[Sesterhenn F.]的文章
[Yang C.]的文章
[Bonet J.]的文章
必应学术
必应学术中相似的文章
[Sesterhenn F.]的文章
[Yang C.]的文章
[Bonet J.]的文章
相关权益政策
暂无数据
收藏/分享

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。